Medical Innovation That Matters
Who We Are
A Commercialization Engine for Medical Device Companies
Alterra Medical is a world-class medical device company with deep experience and proven success in catalyzing, capitalizing and commercializing medical devices. We partner with innovators throughout the entire product lifecycle – from ideation and concept feasibility to case validation and national distribution by our clinically-trained sales team.
How We Can Help
Ecosystem
Reducing Risk At Every Phase of Development
Alterra operates within a unique ecosystem of sister companies that offer expertise at each step of the product development timeline. Working together, we can help fund, de-risk, and commercialize your device.
concept
Ensuring access to capital through both venture funding and investment banking services
concept
development
Selection of target market(s) and indication(s), strategic marketing, and value-add advisory
development
clinical validation
Clinical study design from both physician and payer perspectives
clinical validation
FDA clearance
Regulatory pathway selection and guidance with proper vetting of claims
fda clearance
Successful market penetration through validated sales and distribution channels
development
commercialization
Offers seed-to-exit consulting services to medical device enterprises, including investment banking, payer perspectives and reimbursement advisory
Invests in early-stage biotech and life science companies, providing inflection capital to companies at the critical development stages of innovation, or strategic capital to those in need of value-add advisory or management support
DEVELOPMENT
CONSULTING
Advising innovators on the journey from innovation to market adoption with voice-of-customer research, KOL engagement and critical clinical validation studies
Strategic management
Providing hands-on execution support, from channel and distributor management to national GPO contracting
sales & distribution
Helping companies scale through case support and focused commercialization efforts, both in the U.S. and in key international markets
